Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran-Reference-Cited by-同舟云学术

Budget and health impact of switching eligible patients with atrial fibrillation to lower- dose dabigatran

Published:2023-09-04 Issue:1 Volume:11 Page:
ISSN:2001-6689
Container-title:Journal of Market Access & Health Policy
language:en
Short-container-title:Journal of Market Access & Health Policy

Author:

Fens Tanja¹²^ORCID,de Jong Lisa¹²^ORCID,Kappelhoff Bregt³^ORCID,Boersma Cornelis¹²⁴^ORCID,Postma Maarten J.¹²⁴⁵⁶^ORCID

Affiliation:

1. Department of Health Sciences, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

2. Health-Ecore Ltd, Groningen/Zeist, The Netherlands

3. Department of Market Access & Healthcare Affaires, Boehringer Ingelheim bv, Amsterdam, The Netherlands

4. Department of Management Sciences, Open University, Heerlen, The Netherlands

5. Department of Economics, Econometrics & Finance, Faculty of Economics & Business, University of Groningen, Groningen, The Netherlands

6. Department of Pharmacology and Therapy, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

Publisher

MDPI AG

Subject

Health Informatics,Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/20016689.2023.2247719

Reference74 articles.

1. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

2. World Health Organization Study: Atrial fibrillation is a growing global health concern. [cited 2021 May 22]. Available from: https://www.cedars-sinai.org/newsroom/world-health-organization-study-atrial-fibrillation-is-a-growing-global-health-concern/

3. Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association

4. Global variations in the prevalence, treatment, and impact of atrial fibrillation in a multi-national cohort of 153 152 middle-aged individuals

5. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060